Care Update for Newborn With Meconium-Stained Amniotic Fluid

Share this content:
Care Update for Newborn With Meconium-Stained Amniotic Fluid
Care Update for Newborn With Meconium-Stained Amniotic Fluid

TUESDAY, Feb. 28, 2017 (HealthDay News) -- In a Committee Opinion published in the March issue of Obstetrics & Gynecology, guidelines are updated for the management of delivery of newborns with meconium-stained amniotic fluid.

Michael D. Moxley, M.D., and colleagues from the American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, updated the 2005 guidelines on management of newborns with meconium-stained amniotic fluid.

The authors note that according to the new guidelines, routine intubation and tracheal suctioning are no longer required for newborns with meconium-stained amniotic fluid. The infant may stay with the mother to receive the initial steps of newborn care if the infant is vigorous with good respiratory effort and muscle tone. The initial steps of resuscitation should be completed under the radiant warmer if the infant born through meconium-stained amniotic fluid presents with poor muscle tone and inadequate breathing efforts. For each infant, appropriate intervention to support ventilation and oxygenation should be initiated as indicated. Routine intrapartum suctioning should not be given to infants with meconium-stained amniotic fluid, whether or not the infants are vigorous.

"Meconium-stained amniotic fluid is a condition that requires the notification and availability of an appropriately credentialed team with full resuscitation skills, including endotracheal intubation," the authors write. "Resuscitation should follow the same principles for infants with meconium-stained fluid as for those with clear fluid."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

FDA Approves Ocrevus to Treat Severe Form of ...

First drug sanctioned in United States for primary progressive multiple sclerosis

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

Study Explores Links Between Zika, GBS, Microcephaly in ...

Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly

Inadvertent HPV Vax Doesn't Up Risk of Poor Pregnancy Outcomes

Inadvertent HPV Vax Doesn't Up Risk of Poor ...

No increased risk of major birth defect, spontaneous abortion, preterm birth, low birth weight, SGA

is free, fast, and customized just for you!

Already a member?

Sign In Now »